Tongyuan Li
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 0.5%
- Oncology top 5%
- Immunology top 10%
- Topics
- Cancer-related Molecular Pathways (5 papers)RNA modifications and cancer (4 papers)Epigenetics and DNA Methylation (4 papers)
- Journals
- NatureCellNature Cell Biology
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Tongyuan Li
11 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Molecular Biology 3.0k
- Pulmonary and Respiratory Medicine 2.5k
- Cancer Research 2.2k
- Oncology 933
- Immunology 233
Countries citing papers authored by Tongyuan Li
This map shows the geographic impact of Tongyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongyuan Li more than expected).
Fields of papers citing papers by Tongyuan Li
This network shows the impact of papers produced by Tongyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongyuan Li. The network helps show where Tongyuan Li may publish in the future.
Co-authorship network of co-authors of Tongyuan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Tongyuan Li. A scholar is included among the top collaborators of Tongyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongyuan Li. Tongyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathwaybreakdown → | 704 |
| 2 | 17 | |
| 3 | 3 | |
| 4 | 67 | |
| 5 | Ferroptosis as a p53-mediated activity during tumour suppressionbreakdown → | 2549 |
| 6 | 44 | |
| 7 | 1 | |
| 8 | Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescencebreakdown → | 735 |
| 9 | 72 | |
| 10 | 41 | |
| 11 | 72 |
About Tongyuan Li
Tongyuan Li is a scholar working on Oncology, Molecular Biology and Cancer Research, having authored 11 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (2.2k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Molecular Biology (3.0k citations). Tongyuan Li has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Le Jiang, Ning Kon, Wei Gu, Richard Baer, Shang-Jui Wang, Tao Su, Hanina Hibshoosh, Thomas Ludwig, Yingming Zhao and Minjia Tan. Their work appears in journals such as Nature, Cell and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.